[1]BormioNunes,JuliaH.;Hager,Sonja;Mathuber,Marlene;Pósa,Vivien;Roller,Alexander;Enyedy,ÉvaA.;Stefanelli,Alessia;Berger,Walter;Keppler,BernhardK.;Heffeter,Petra;Kowol,ChristianR.[JournalofMedicinalChemistry,2020,vol.63,#22,p.13719-13732]
[1]BormioNunes,JuliaH.;Hager,Sonja;Mathuber,Marlene;Pósa,Vivien;Roller,Alexander;Enyedy,ÉvaA.;Stefanelli,Alessia;Berger,Walter;Keppler,BernhardK.;Heffeter,Petra;Kowol,ChristianR.[JournalofMedicinalChemistry,2020,vol.63,#22,p.13719-13732]
[1]BormioNunes,JuliaH.;Hager,Sonja;Mathuber,Marlene;Pósa,Vivien;Roller,Alexander;Enyedy,ÉvaA.;Stefanelli,Alessia;Berger,Walter;Keppler,BernhardK.;Heffeter,Petra;Kowol,ChristianR.[JournalofMedicinalChemistry,2020,vol.63,#22,p.13719-13732]
[1]BormioNunes,JuliaH.;Hager,Sonja;Mathuber,Marlene;Pósa,Vivien;Roller,Alexander;Enyedy,ÉvaA.;Stefanelli,Alessia;Berger,Walter;Keppler,BernhardK.;Heffeter,Petra;Kowol,ChristianR.[JournalofMedicinalChemistry,2020,vol.63,#22,p.13719-13732]
Title: Duffy MJ, et al. Mutant p53 as a target for cancer treatment. Eur J Cancer. 2017 Sep;83:258-265.
Title: Salim KY, et al. COTI-2, a novel small molecule that is active against multiple human cancer cell lines in vitro and in vivo. Oncotarget. 2016 Jul 5;7(27):41363-41379.
Title: Lindemann A, et al. COTI-2, A Novel Thiosemicarbazone Derivative, Exhibits Antitumor Activity in HNSCC through p53-dependent and -independent Mechanisms. Clin Cancer Res. 2019 Sep 15;25(18):5650-5662.